0001193125-19-305378.txt : 20191203 0001193125-19-305378.hdr.sgml : 20191203 20191203170709 ACCESSION NUMBER: 0001193125-19-305378 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20191203 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20191203 DATE AS OF CHANGE: 20191203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 133757370 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 191266423 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 8-K 1 d841237d8k.htm 8-K 8-K
LABORATORY CORP OF AMERICA HOLDINGS NYSE false 0000920148 0000920148 2019-12-03 2019-12-03

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 3, 2019 

 

LABORATORY CORPORATION OF AMERICA HOLDINGS

(Exact name of registrant as specified in Charter) 

 

Delaware

  

1-11353

  

13-3757370

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(I.R.S. Employer

Identification No.)

358 South Main Street,

Burlington, North Carolina

  

27215

(Address of principal executive offices)

  

(Zip Code)

336-229-1127

Registrant’s telephone number, including area code

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

  ☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

  ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

  ☐ Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

  ☐ Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

  

Trading

Symbol(s)

  

Name of each exchange

on which registered

Common Stock, $0.10 par value

  

LH

  

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

Item 7.01 Regulation FD Disclosure.

On December 3, 2019, Laboratory Corporation of America Holdings (“LabCorp”) issued a press release announcing the early results of its previously announced cash tender offer (the “Offer”) for up to $300,000,000 principal amount of its outstanding $600,000,000 aggregate principal amount of 4.625% Senior Notes due 2020 (the “Notes”).

On December 3, 2019, LabCorp also issued a press release announcing the pricing terms of its previously announced Offer.

Copies of the press releases are attached to this Current Report on Form 8-K as Exhibit 99.1 and 99.2 and are incorporated herein by reference.

The announcements related to the Offer are neither an offer to purchase nor a solicitation of an offer to sell the Notes. The Offer is being made solely by means of the Offer to Purchase that LabCorp distributed to holders of the Notes.

Item 9.01 Financial Statements and Exhibits

(d)

         
 

99.1

   

Press Release dated December 3, 2019 issued by LabCorp titled “LabCorp announces early results of its tender offer for up to $300,000,000 principal amount of its outstanding 4.625% Senior Notes due 2020”

         
 

99.2

   

Press Release dated December 3, 2019 issued by LabCorp titled “LabCorp announces pricing terms of its tender offer for up to $300,000,000 principal amount of its outstanding 4.625% Senior Notes due 2020”

         
 

104

   

Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

LABORATORY CORPORATION OF AMERICA HOLDINGS

 

 

Registrant

Date: December 3, 2019

  

 

 

             

 

 

By:

 

/s/ Sandra D. van der Vaart

 

 

 

Sandra D. van der Vaart

 

 

 

Senior Vice President, Global General Counsel and Secretary

EX-99.1 2 d841237dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

FOR IMMEDIATE RELEASE

LabCorp Contacts:

Investors: Clarissa Willett — 336-436-5076

Investor@LabCorp.com

Media: Pattie Kushner — 336-436-8263

Media@LabCorp.com

LABCORP ANNOUNCES EARLY RESULTS OF ITS TENDER OFFER FOR UP TO $300,000,000 PRINCIPAL AMOUNT OF ITS OUTSTANDING 4.625% SENIOR NOTES DUE 2020

BURLINGTON, N.C., Dec. 3, 2019 — LabCorp® (NYSE: LH) announced today the early results of its previously announced cash tender offer (the Offer) for up to $300,000,000 principal amount (the Tender Cap) of its outstanding $600,000,000 aggregate principal amount of 4.625% Senior Notes due 2020 (the Notes). The terms and conditions of the Offer are described in the Offer to Purchase dated Nov. 18, 2019 (the Offer to Purchase) and remain unchanged.

The following table sets forth certain information regarding the Offer, including the aggregate principal amount of Notes that were validly tendered and not withdrawn at or prior to 5:00 p.m. EST on Dec. 2, 2019 (the Early Tender Deadline) and the aggregate principal amount of Notes to be accepted for purchase by LabCorp:

 

Title of Security

    CUSIP
Number		      Principal
Amount
Outstanding		      Tender Cap
(Principal
Amount)		      Notes
Tendered
(Principal
Amount)		      Notes
Accepted
(Principal
Amount)		  

4.625% Senior Notes due 2020

      50540RAJ1      $ 600,000,000      $ 300,000,000      $ 174,863,000      $ 174,863,000  

LabCorp will accept all Notes validly tendered and not validly withdrawn at or prior to the Early Tender Deadline, and expects to make payment for the Notes on Dec. 4, 2019 (the Early Settlement Date).

The deadline to validly withdraw tenders has passed. Accordingly, Notes that were already tendered at the Early Tender Deadline may not be withdrawn, except in certain limited circumstances where additional withdrawal rights are required by law.

As previously announced, the total consideration (the Total Consideration) payable for the Notes will be determined at 10:00 a.m. EST today, Dec. 3, 2019, as described in the Offer to Purchase. Holders of Notes validly tendered and not validly withdrawn at or prior to the Early Tender Deadline and accepted for purchase will be eligible to receive the Total Consideration, which will include an early tender premium of $30.00 per $1,000 principal amount of the Notes accepted for purchase (the Early Tender Premium).

LabCorp will continue to accept Notes tendered after the Early Tender Deadline up to the Tender Cap. The Offer will expire at 11:59 p.m. EST on Dec. 16, 2019, unless extended or earlier terminated by LabCorp (the Expiration Date). Holders of Notes who validly tender their Notes following the Early Tender Deadline and on or prior to the Expiration Date will receive the “Tender Offer Consideration” per $1,000 principal amount of any such Notes tendered by such holders that are accepted for purchase, which is equal to the Total Consideration minus the Early Tender Premium. Holders of Notes accepted for purchase by LabCorp will also receive accrued interest from the most recent interest payment date for the Notes up to, but not including, the applicable settlement date. Notes may be subject to proration if the aggregate principal amount of the Notes validly tendered is greater than the Tender Cap.

BofA Securities, US Bancorp, and Wells Fargo Securities are acting as dealer managers for the tender offer. The tender agent and information agent for the tender offer is D.F. King & Co., Inc. Questions regarding the tender offer may be directed to BofA Securities at (980) 387-3907 (collect) or (888) 292-0070 (U.S. toll-free), US Bancorp at (612) 336-7604 (collect) or (877) 558-2607 (U.S. toll-free), and Wells Fargo Securities at (704) 410-4759 (collect) or (866) 309-6316 (U.S. toll-free). Holders who would like additional copies of the offer documents may call the information agent, D.F. King & Co., Inc. at (212) 269-5550 (collect, for banks and brokers) or (888) 625-2588 (toll-free, for all others), or by e-mail at labcorp@dfking.com.

This press release is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell the Notes. The tender offer is being made solely by means of the Offer to Purchase that LabCorp distributed to holders of Notes.

About LabCorp

LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory, and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster, and uses technology to improve the delivery of care. LabCorp reported revenue of more than $11 billion in 2018. To learn more about LabCorp, visit www.LabCorp.com, and to learn more about Covance Drug Development, visit www.Covance.com. The information contained on these websites is not incorporated by reference herein.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements including but not limited to statements pertaining to the Offer. Each of the forward-looking statements is subject to change based on various important factors. Actual results of the Offer could differ materially from those suggested by these forward-looking statements. LabCorp has no obligation to provide any updates to these forward-looking statements even if its expectations change. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. Further information on potential factors, risks, and uncertainties that could affect operating and financial results is included in LabCorp’s most recent Annual Report on Form 10-K and subsequent Forms 10-Q, including in each case under the heading RISK FACTORS, and in LabCorp’s other filings with the SEC.

EX-99.2 3 d841237dex992.htm EX-99.2 EX-99.2

Exhibit 99.2

 

LOGO

FOR IMMEDIATE RELEASE

LabCorp Contacts:

Investors: Clarissa Willett — 336-436-5076

Investor@LabCorp.com

Media: Pattie Kushner — 336-436-8263

Media@LabCorp.com

LABCORP ANNOUNCES PRICING TERMS OF ITS TENDER OFFER FOR UP TO $300,000,000 PRINCIPAL AMOUNT OF ITS OUTSTANDING 4.625% SENIOR NOTES DUE 2020

BURLINGTON, N.C., Dec. 3, 2019 — LabCorp® (NYSE: LH) announced today the pricing terms of its previously announced cash tender offer (the Offer) for up to $300,000,000 principal amount (the Tender Cap) of its outstanding $600,000,000 aggregate principal amount of 4.625% Senior Notes due 2020 (the Notes). The terms and conditions of the Offer are described in the Offer to Purchase dated Nov. 18, 2019 (the Offer to Purchase) and remain unchanged.

The total consideration (the Total Consideration) for the Notes is based on the yield to maturity of the applicable U.S. Treasury Security (the Reference Yield) plus a fixed spread, as set forth in the table below. The Reference Yield (as determined pursuant to the Offer to Purchase) was determined at 10:00 a.m. EST today, Dec. 3, 2019, by the dealer managers (identified below).

The following table sets forth certain information regarding the Offer, including the Reference Yield and the Total Consideration:

 

Title of Security

    CUSIP
Number		    Reference
U.S. Treasury
Security		    Reference
Yield		    Fixed Spread
(basis points)		    Total
Consideration
(per $1,000)

4.625% Senior

Notes due 2020

    50540RAJ1    1.50% UST due

Aug 15, 2020

    1.663%    30 bps    $1,018.36

The Total Consideration is payable to holders of Notes validly tendered and not validly withdrawn at or prior to 5:00 p.m. EST on Dec. 2, 2019 (the Early Tender Deadline) and accepted for purchase by LabCorp. The Total Consideration includes an early tender premium of $30.00 per $1,000 principal amount of Notes validly tendered and not validly withdrawn by such holders and accepted for purchase by LabCorp (the Early Tender Premium). All payments for Notes purchased in connection with the Early Tender Deadline will also include accrued and unpaid interest on the principal amount of Notes tendered up to, but not including, the Early Settlement Date, which is currently expected to be Dec. 4, 2019.

As announced earlier today, LabCorp will accept all Notes validly tendered and not validly withdrawn on or before the Early Tender Deadline. LabCorp will continue to accept Notes tendered after the Early Tender Deadline up to the Tender Cap. Notes may be subject to proration if the aggregate principal amount of the Notes validly tendered is greater than the Tender Cap. The Offer will expire at 11:59 p.m. EST on Dec. 16, 2019, unless extended or earlier terminated by LabCorp (the Expiration Date). Holders of Notes who validly tender their Notes following the Early Tender Deadline and on or prior to the Expiration Date will receive the “Tender Offer Consideration” per $1,000 principal amount of any such Notes tendered by such holders that are accepted for purchase, which is equal to the Total Consideration minus the Early Tender Premium. Holders of Notes accepted for purchase by LabCorp will also receive accrued interest from the most recent interest payment date for the Notes up to, but not including, the applicable settlement date.

The deadline to validly withdraw tenders has passed. Accordingly, Notes that were already tendered at the Early Tender Deadline may not be withdrawn, except in certain limited circumstances where additional withdrawal rights are required by law.

BofA Securities, US Bancorp, and Wells Fargo Securities are acting as dealer managers for the tender offer. The tender agent and information agent for the tender offer is D.F. King & Co., Inc. Questions regarding the tender offer may be directed to BofA Securities at (980) 387-3907 (collect) or (888) 292-0070 (U.S. toll-free), US Bancorp at (612) 336-7604 (collect) or (877) 558-2607 (U.S. toll-free), and Wells Fargo Securities at (704) 410-4759 (collect) or (866) 309-6316 (U.S. toll-free). Holders who would like additional copies of the offer documents may call the information agent, D.F. King & Co., Inc. at (212) 269-5550 (collect, for banks and brokers) or (888) 625-2588 (toll-free, for all others), or by e-mail at labcorp@dfking.com.

This press release is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell the Notes. The tender offer is being made solely by means of the Offer to Purchase that LabCorp distributed to holders of Notes.

About LabCorp

LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory, and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster, and uses technology to improve the delivery of care. LabCorp reported revenue of more than $11 billion in 2018. To learn more about LabCorp, visit www.LabCorp.com, and to learn more about Covance Drug Development, visit www.Covance.com. The information contained on these websites is not incorporated by reference herein.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements including but not limited to statements pertaining to the Offer. Each of the forward-looking statements is subject to change based on various important factors. Actual results of the Offer could differ materially from those suggested by these forward-looking statements. LabCorp has no obligation to provide any updates to these forward-looking statements even if its expectations change. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. Further information on potential factors, risks, and uncertainties that could affect operating and financial results is included in LabCorp’s most recent Annual Report on Form 10-K and subsequent Forms 10-Q, including in each case under the heading RISK FACTORS, and in LabCorp’s other filings with the SEC.

EX-101.SCH 4 lh-20191203.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 5 lh-20191203_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Entity Registrant Name Entity Registrant Name Security Exchange Name Security Exchange Name Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 6 lh-20191203_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 7 g841237g1203094837806.jpg GRAPHIC begin 644 g841237g1203094837806.jpg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end GRAPHIC 8 g841237g1203211901180.jpg GRAPHIC begin 644 g841237g1203211901180.jpg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end JSON 9 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d841237d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d841237d8k.htm" ] }, "labelLink": { "local": [ "lh-20191203_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "lh-20191203_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "lh-20191203.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 4, "total": 4 }, "keyCustom": 0, "keyStandard": 97, "memberCustom": 0, "memberStandard": 0, "nsprefix": "lh", "nsuri": "http://www.labcorp.com/20191203", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "d841237d8k.htm", "contextRef": "duration_2019-12-03_to_2019-12-03", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "d841237d8k.htm", "contextRef": "duration_2019-12-03_to_2019-12-03", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3 html 1 97 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.labcorp.com//20191203/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d841237d8k.htm d841237dex991.htm d841237dex992.htm lh-20191203.xsd lh-20191203_lab.xml lh-20191203_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false XML 14 R1.htm IDEA: XBRL DOCUMENT v3.19.3
Document and Entity Information
Dec. 03, 2019
Cover [Abstract]  
Entity Registrant Name LABORATORY CORP OF AMERICA HOLDINGS
Security Exchange Name NYSE
Amendment Flag false
Entity Central Index Key 0000920148
Document Type 8-K
Document Period End Date Dec. 03, 2019
Entity Incorporation State Country Code DE
Entity File Number 1-11353
Entity Tax Identification Number 13-3757370
Entity Address, Address Line One 358 South Main Street
Entity Address, City or Town Burlington
Entity Address, State or Province NC
Entity Address, Postal Zip Code 27215
City Area Code 336
Local Phone Number 229-1127
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.10 par value
Trading Symbol LH
Entity Emerging Growth Company false
XML 15 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} EXCEL 16 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end ZIP 17 0001193125-19-305378-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-19-305378-xbrl.zip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end XML 18 d841237d8k_htm.xml IDEA: XBRL DOCUMENT 0000920148 2019-12-03 2019-12-03 LABORATORY CORP OF AMERICA HOLDINGS NYSE false 0000920148 8-K 2019-12-03 DE 1-11353 13-3757370 358 South Main Street Burlington NC 27215 336 229-1127 false false false false Common Stock, $0.10 par value LH false